Cannara Biotech Inc.
Research Cannara Biotech Inc. (LOVE.TO) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerLOVE.TO
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCAD
- Financial periodQ2 2026
- RevenueCAD 31.83M
- Net incomeCAD 4.84M
- Free cash flowCAD 1.28M
- Gross margin47.2%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 112.25M | CAD 11.81M | CAD 12.38M | 42.9% | n/a | CAD 16.52M | CAD 34.80M | CAD 111.21M |
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does Cannara Biotech Inc. do?
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.